Metrics From Wearable Devices Can Predict IBD Flares
Heart rate variability, heart rate, resting heart rate, steps, and oxygenation altered up to seven weeks before flares
Guidance Developed for Diagnosis, Management of Eosinophilic Esophagitis
Suggested treatments for eosinophilic esophagitis include PPIs, topical steroids, empiric food elimination diet, biologics, endoscopic dilation
Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal Cancer
Improved survival seen with perioperative chemotherapy with FLOT versus preoperative chemoradiotherapy
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders
Racial, Sex Disparities Seen in Discussion of, Progression to Weight Loss Surgery
Black patients equally likely to discuss, less likely to progress to metabolic and bariatric surgery than non-Black patients
PFAS in Drinking Water Linked to Increased Cancer Incidence
Increased cancer incidence seen in digestive, endocrine, oral cavity/pharynx, and respiratory systems between 2016 and 2021
TACE + Lenvatinib, Pembrolizumab Tied to Improved Survival in Unresectable Liver Cancer
Clinically meaningful improvement seen in progression-free survival for transarterial chemoembolization plus lenvatinib and pembrolizumab
Cancer Mortality Continued to Decline Through 2022
However, increase seen in incidence in women, especially for middle-aged and younger women
FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
Approval based on results from phase 3 VIVID-1 trial, in which end points of clinical remission and endoscopic response were met at one year
Gastric Cancer Is a Considerable Health Concern Worldwide
Male predominance seen in global GC cases and deaths; highest burden seen in cases and deaths in East Asia
